Insider Shareholders with Direct Ownership of Neuro Bo Pharmaceuticals, Inc. (NRBO)
This section provides a comprehensive overview of the insiders with direct ownership of Neuro Bo Pharmaceuticals, Inc. (NRBO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NeuroBo Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 7,192,417 | 407 | 9,995,679 $16.3 Million | 3 |
May 08, 2025
Added 31.74%
|
|
|
Na Yeon Kim
Director |
100,000 | 0 | 101,459 $165,378 | 1 |
Jul 27, 2023
Added 10.97%
|
|
Hyung Heon Kim
CEO & President |
625,064 | 17,129 | 61,004 $99,436 | 4 |
Mar 01, 2025
Reduced 4.38%
|
|
Andrew I Koven
Director |
133,198 | 0 | 45,699 $74,489 | 3 |
Jun 30, 2025
Added 38.12%
|
|
D Gordon Strickland
Director |
133,198 | 0 | 45,699 $74,489 | 3 |
Jun 30, 2025
Added 38.12%
|
|
Jason L Groves
Director |
133,198 | 0 | 45,699 $74,489 | 3 |
Jun 30, 2025
Added 38.12%
|
|
Michael Salsbury
Director |
133,198 | 0 | 45,699 $74,489 | 3 |
Jun 30, 2025
Added 38.12%
|
|
Mark A Glickman
Director |
70,698 | 0 | 37,887 $61,755 | 3 |
Jun 30, 2025
Added 42.63%
|
|
James Patrick Tursi
Director |
65,355 | 0 | 37,219 $60,666 | 3 |
Jun 30, 2025
Added 43.06%
|
|
Marshall H Woodworth
Chief Financial Officer |
47,696 | 17,617 | 30,079 $49,028 | 4 |
Aug 12, 2025
Reduced 32.07%
|
|
Akash Bakshi
SVP and COO |
29,013 | 0 | 29,013 $47,291 | 1 |
Dec 31, 2020
Added 50.0%
|